MYDGF can promote self-renewal of liver tumor stem cells and tumor angiogenesis, induce macrophage chemotaxis into tumor tissues and release a variety of inflammatory factors, which ultimately aggravate inflammation in the tumor microenvironment and accelerate HCC progression (Wang et al. 2021). Here, MYDGF is linked to neoplasm.